Matches in SemOpenAlex for { <https://semopenalex.org/work/W2166335411> ?p ?o ?g. }
- W2166335411 endingPage "746" @default.
- W2166335411 startingPage "738" @default.
- W2166335411 abstract "Purpose This study explores the implications for cancer induction of treatment details such as fractionation, planning target volume (PTV) definition, and interpatient variations, which are relevant for the radiation treatment of prostate carcinomas. Methods and Materials Treatment planning data from 100 patients have been analyzed with a risk model based on the United Nations Scientific Committee on the Effects of Atomic Radiation competition model. The risk model can account for dose heterogeneity and fractionation effects characteristic for modern radiotherapy. Biologically relevant parameters from clinical and experimental data have been used with the model. Results The results suggested that changes in prescribed dose could lead to a modification of the risks for individual organs surrounding the clinical target volume (CTV) but that the total risk appears to be less affected by changes in the target dose. Larger differences are observed for modifications of the margins between the CTV and the PTV because these have direct impact onto the dose level and dose heterogeneity in the healthy tissues surrounding the CTV. Interpatient anatomic variations also have to be taken into consideration for studies of the risk for cancer induction from radiotherapy. Conclusions The results have shown the complex interplay between the risk for secondary malignancies, the details of the treatment delivery, and the patient heterogeneity that may influence comparisons between the long-term effects of various treatment techniques. Nevertheless, absolute risk levels seem very small and comparable to mortality risks from surgical interventions, thus supporting the robustness of radiation therapy as a successful treatment modality for prostate carcinomas. This study explores the implications for cancer induction of treatment details such as fractionation, planning target volume (PTV) definition, and interpatient variations, which are relevant for the radiation treatment of prostate carcinomas. Treatment planning data from 100 patients have been analyzed with a risk model based on the United Nations Scientific Committee on the Effects of Atomic Radiation competition model. The risk model can account for dose heterogeneity and fractionation effects characteristic for modern radiotherapy. Biologically relevant parameters from clinical and experimental data have been used with the model. The results suggested that changes in prescribed dose could lead to a modification of the risks for individual organs surrounding the clinical target volume (CTV) but that the total risk appears to be less affected by changes in the target dose. Larger differences are observed for modifications of the margins between the CTV and the PTV because these have direct impact onto the dose level and dose heterogeneity in the healthy tissues surrounding the CTV. Interpatient anatomic variations also have to be taken into consideration for studies of the risk for cancer induction from radiotherapy. The results have shown the complex interplay between the risk for secondary malignancies, the details of the treatment delivery, and the patient heterogeneity that may influence comparisons between the long-term effects of various treatment techniques. Nevertheless, absolute risk levels seem very small and comparable to mortality risks from surgical interventions, thus supporting the robustness of radiation therapy as a successful treatment modality for prostate carcinomas." @default.
- W2166335411 created "2016-06-24" @default.
- W2166335411 creator A5001334476 @default.
- W2166335411 creator A5026199499 @default.
- W2166335411 creator A5060502849 @default.
- W2166335411 creator A5085257851 @default.
- W2166335411 creator A5085716681 @default.
- W2166335411 date "2011-03-01" @default.
- W2166335411 modified "2023-10-01" @default.
- W2166335411 title "Secondary Malignancies From Prostate Cancer Radiation Treatment: A Risk Analysis of the Influence of Target Margins and Fractionation Patterns" @default.
- W2166335411 cites W1965262598 @default.
- W2166335411 cites W1966868305 @default.
- W2166335411 cites W1968324807 @default.
- W2166335411 cites W1968339106 @default.
- W2166335411 cites W1996796091 @default.
- W2166335411 cites W1998252104 @default.
- W2166335411 cites W1998263434 @default.
- W2166335411 cites W2005121044 @default.
- W2166335411 cites W2016494784 @default.
- W2166335411 cites W2016917978 @default.
- W2166335411 cites W2018241425 @default.
- W2166335411 cites W2029266086 @default.
- W2166335411 cites W2039139527 @default.
- W2166335411 cites W2044649803 @default.
- W2166335411 cites W2047206701 @default.
- W2166335411 cites W2049806725 @default.
- W2166335411 cites W2052579544 @default.
- W2166335411 cites W2053987315 @default.
- W2166335411 cites W2064291232 @default.
- W2166335411 cites W2066931933 @default.
- W2166335411 cites W2082173698 @default.
- W2166335411 cites W2087044912 @default.
- W2166335411 cites W2092227832 @default.
- W2166335411 cites W2097228107 @default.
- W2166335411 cites W2097691703 @default.
- W2166335411 cites W2099156085 @default.
- W2166335411 cites W2110998462 @default.
- W2166335411 cites W2115475605 @default.
- W2166335411 cites W2117285637 @default.
- W2166335411 cites W2120469506 @default.
- W2166335411 cites W2124435581 @default.
- W2166335411 cites W2149642768 @default.
- W2166335411 cites W2159598747 @default.
- W2166335411 cites W2167713059 @default.
- W2166335411 cites W2168571815 @default.
- W2166335411 cites W2346397638 @default.
- W2166335411 cites W2348313778 @default.
- W2166335411 cites W2970875601 @default.
- W2166335411 cites W2998218525 @default.
- W2166335411 cites W62081220 @default.
- W2166335411 cites W3146401935 @default.
- W2166335411 doi "https://doi.org/10.1016/j.ijrobp.2009.12.004" @default.
- W2166335411 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20472345" @default.
- W2166335411 hasPublicationYear "2011" @default.
- W2166335411 type Work @default.
- W2166335411 sameAs 2166335411 @default.
- W2166335411 citedByCount "16" @default.
- W2166335411 countsByYear W21663354112012 @default.
- W2166335411 countsByYear W21663354112013 @default.
- W2166335411 countsByYear W21663354112014 @default.
- W2166335411 countsByYear W21663354112015 @default.
- W2166335411 countsByYear W21663354112016 @default.
- W2166335411 countsByYear W21663354112017 @default.
- W2166335411 countsByYear W21663354112018 @default.
- W2166335411 countsByYear W21663354112020 @default.
- W2166335411 countsByYear W21663354112021 @default.
- W2166335411 crossrefType "journal-article" @default.
- W2166335411 hasAuthorship W2166335411A5001334476 @default.
- W2166335411 hasAuthorship W2166335411A5026199499 @default.
- W2166335411 hasAuthorship W2166335411A5060502849 @default.
- W2166335411 hasAuthorship W2166335411A5085257851 @default.
- W2166335411 hasAuthorship W2166335411A5085716681 @default.
- W2166335411 hasConcept C121608353 @default.
- W2166335411 hasConcept C125118446 @default.
- W2166335411 hasConcept C126322002 @default.
- W2166335411 hasConcept C143998085 @default.
- W2166335411 hasConcept C155806632 @default.
- W2166335411 hasConcept C178790620 @default.
- W2166335411 hasConcept C185592680 @default.
- W2166335411 hasConcept C201645570 @default.
- W2166335411 hasConcept C2776235491 @default.
- W2166335411 hasConcept C2780192828 @default.
- W2166335411 hasConcept C2989005 @default.
- W2166335411 hasConcept C509974204 @default.
- W2166335411 hasConcept C71924100 @default.
- W2166335411 hasConcept C97428945 @default.
- W2166335411 hasConceptScore W2166335411C121608353 @default.
- W2166335411 hasConceptScore W2166335411C125118446 @default.
- W2166335411 hasConceptScore W2166335411C126322002 @default.
- W2166335411 hasConceptScore W2166335411C143998085 @default.
- W2166335411 hasConceptScore W2166335411C155806632 @default.
- W2166335411 hasConceptScore W2166335411C178790620 @default.
- W2166335411 hasConceptScore W2166335411C185592680 @default.
- W2166335411 hasConceptScore W2166335411C201645570 @default.
- W2166335411 hasConceptScore W2166335411C2776235491 @default.
- W2166335411 hasConceptScore W2166335411C2780192828 @default.
- W2166335411 hasConceptScore W2166335411C2989005 @default.
- W2166335411 hasConceptScore W2166335411C509974204 @default.